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Studies on the Uptake, Metabolism, and
Release of Endogenous and Exogenous
Chemicals by Use of the Isolated
Perfused Lung
by M. W. Anderson* and T. E. Eling*
The isolated perfused lungis a valuable tool for studying many lung functions. The kinds ofin-
formation one can obtain from the isolated perfused lung are illustrated by examples from our
studies on the uptake, accumulation, and metabolism ofendogenous andexogenous chemicals.
In recent years it has been recognized that the
lung possesses a number of important functions
other than serving as an organ for the exchange
of gases. It has often been assumed that the lung
plays only a passive role in the removal and me-
tabolism of various chemicals from the circula-
tion. Today it is recognized that the lung serves
as a filter for the blood, removing and detoxifying
various endogenous substances; for example, 5-
hydroxytryptamine (5-HT), norepinephrine (NE),
and prostaglandin (PG) (1) and in other cases ac-
tivating endogenous substances, e.g., angioten-
sin. Under normal conditions or under stress, the
lung serves as an endocrine organ releasing vaso-
active material into the circulation (1). In addi-
tion, the lung possesses the ability to metabolize
exogenous chemicals (2). Since the lung is in
direct contact with the environment, toxicity pro-
duced by environmental chemicals may be related
tothese nonrespiratory functions.
Many studies on the nonrespiratory lung func-
tions have been made possible or aided by the
isolated perfused lung preparation (IPL). We
* Pharmacology Branch, National Institute of Environmen-
tal Health Sciences, Research Triangle Park, N. C. 27709.
have used this isolated perfused rat and rabbit
lung preparation to examine the uptake and me-
tabolism ofvarious chemicals. Figure 1 illustrates
our IPL, which is a modification of the basic lung
perfusion technique developed by Niemeyer and
Bingham (3). Our modified perfusion apparatus
can be used in three ways: (1) the perfusate or
blood is recirculated, and the uptake and metab-
olism of a chemical by the lung is investigated by
examination of the changes in the perfusate con-
centrations with time; (2) the perfusate is not
recirculated (single pass), the labeled test com-
pounds and labeled vascular maker dextran being
injected as a bolus into the pulmonary artery and
the effluent collected as a series of timed sam-
ples; (3) the perfusate is not recirculated, but
lungs being perfused with "chemical-free" media
are then perfused with perfusate containing the
test compound. Effluent from the lungis collected
as a series of timed samples during this time. In
addition, the efflux of accumulated chemicals
from the lung can then be studied by perfusing
with "chemical-free" perfusate.
From each of these types of experiments one
can obtain a variety ofinformation concerning the
uptake, accumulation, release and metabolism of
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FIGURE 1. Schematic diagram ofisolated perfused lung (IPL).
chemicals from the lung. We would like to illus-
trate this point using an example from our work.
We have studied the accumulation and metabo-
lism of a number of xenobiotics by the recir-
culating rabbit IPL (4-6). As illustrated in Figure
2, the basic amine, methadone, rapidly disappears
from the circulation and accumulates in the lung.
Metabolites of methadone slowly appear in the
perfusate. By using this technique, we found that
the rabbit IPL metabolized methadone, chlorcy-
clizine, pentobarbital, and parathion but did not
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FIGURE 2. Disappearance of methadone and appearance of me-
tabolites in perfusate of isolated perfused lung: (-) concen-
tration of methadone: (0) concentration of metabolites, both
expressed as nmole/ml of perfusate. Methadone (6 ymole)
was added to 120 ml of perfusate. At the end of 120 min the
lung contained approximately 26 nmole methadone/g oflung
and 24 nmole metabolites/g oflung.
degrade imipramine (IMIP). However, all these
chemicals, including imipramine, were degraded
by lung homogenates or subcellular fractions, in-
dicating important differences between metabo-
lism in vitro and metabolism by IPL. Also, basic
amines were found to accumulate in lung tissue
with high tissue-to-blood ratios. By examination
of the steady-state accumulation, we found that
several mechanism(s) were responsible forthe ac-
cumulation ofbasic amines in lung tissue (4,5).
The single pass or nonrecirculating IPL is use-
ful for examining the removal, metabolism, and
release of chemicals by the lung. We have used
these techniques to examine the accumulation of
basic amines by the lung. The lung can be per-
fused with a constant concentration of a chemical
and then the efflux of that accumulated chemical
from the lung examined. Using this procedure we
studied the accumulation of the basic amine (imi-
pramine and methadone) by the lung. The rate of
efflux of accumulated imipramine (Fig. 3) was re-
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FIGURE 3. Variation with time of the efflux rate of 14C-
imipramine from the isolated perfused rabbit lung. Efflux
rate (on a logarithmic scale) (jumole/sec) is plotted against
the time after infusion of '4C-imipramine into the pulmonary
artery at a concentration of 0.0048 jAmole/ml. The solid lines
represent the exponential components obtained by nonlinear
regression analysis.
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various pool or binding sites for the IMIP. Each of
these pools, with its half-life, is in part responsi-
ble for the high accumulation ofIMIP found in the
lung. Further examination of these efflux rates
indicated a pool with a half-life in excess of 5 hr
and that the amount of imipramine remaining in
the lung appeared to approach a constant amount
(Fig. 4). The pool (or pools) did not result from ir-
reversible binding and appeared to be associated
with the phospholipid in the lung. We think that
this pool is responsible for the persistence of im-
ipramine and other basic amines in lung tissue
and may be associated with drug-induced phos-
pholipidosis (7).
Single-pass IPL preparations are also useful in
examining the mechanism responsible for the re-
moval of chemicals from the circulation by the
10r 1
08
n
w
0 E
C.
c
6)
0)
.E
1._
c
c- E
0.6k
0.4t
0.2
0.1 10 20 30 40
Efflux time(min)
50 60
FIGURE 4. Time dependence of imipramine efflux from the
isolated perfused rabbit lung. Lungs were infused with
imipramine at a concentration of 0.0048 ,Amole/ml for 8 min,
and the efflux of accumulated imipramine examined after
cessation of the infusion. The amount of 14C-imipramine in
the lung is plotted against the time ofefflux.
lung. We have used these methods for examining
the detoxification ofprostaglandins by the lung.
It has been established that the lung extensive-
ly degrades circulating prostaglandins (8). The
enzymes responsible for this PG metabolism are
found in the 100,000 g supernatant fraction of
lung and thus are presumably found in the cyto-
sol. Removal of PG was investigated by bolus in-
jections of 3H-PGF2<, and the vascular marker
'4C-dextran into the pulmonary artery of the iso-
lated perfused lung. 3H-PGF2a metabolites ap-
peared in the venous effluent at a later time than
than the "4C-dextran (Fig. 5), which indicated a
rapid uptake and release ofPG by the lung. 3H-PGB1
or 3H-PGA1 was also injected as a bolus with the
vascular marker 14C-dextran. These prostaglan-
dins appeared with the '4C-dextran in the effluent
and no metabolites were detected, indicating lit-
tle or no removal of these PG by the lung. In con-
trast, PGE1, PGF2a, and PGA1 were degraded in
vitro by the 100,00g supernatant. This selective
degradation of PG by the lung in vivo indicates
selective removal of the PG from the circulation.
These data imply that PGEl and PGF2a are
removed from the circulation by a transport
system rather than by diffusion or binding.
To establish the existence of a pulmonary
transport for PG, it is necessary to examine the
unidirectional flux of the PG into the lung tissue.
Rat lungs were perfused with either 3H-PGE1 or
3H-PGF20, and the vascular marker 14C-dextran at
a final concentration and flow rate. By measuring
the radioactivity in the effluent one can calculate
the net rate of flux of radioactivity into the lung,
as seen in Figure 6. After subtraction of the dex-
tran dilution into the vascular space the rate of
PG flux from the perfusate into the lung was es-
timated by extrapolation to zero time indicated
6000 0
-- * Dextron
I .~~~~~~~~aPGF2.~
600C- 0 it| \ ' " 15-Keto-PGF2., I1 l .A " ^ 15-Keto-13,14-
S dihydroPGF.,
0-
2000-
E
0~~~~~~~N = t41_00_ N-
O ._ __ __ _ 10 20 30
Sample No.(2sq-1.14sec.)
40 50
FIGURE 5. Appearance of "4C-dextran, 3H-PGF2a, and
metabolites in the venous effluent after a bolus injection into
the pulmonary artery ofIPL.
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FIGURE 6. Variation with time of the net removal rate of
radioactivity in IPL during a constant perfusion with 3H-
PGF2e and '4C-dextran. The lung was perfused at 30 ml/min
with 3H-PGF2. and '4C-dextran at a level of 0.594 nmole/ml:
(.) 3H-PGF2. and metabolites; (0) difference between the
14C-dextran and 3H-PGF2. influx velocities. The arrow
denotes the time when the difference in the dextran and
PGF2e rates was at maximum.
by the arrow. At zero time, no PG has accumu-
lated in the lung and no metabolism has occurred.
The rate of PG flux was then investigated at var-
ious perfusate concentrations. The unidirectional
flux of PGE1 saturated with respect to supply
rate (Fig. 7). This hyperbolic relationship is con-
sistent with the hypothesis that PGE1 is removed
from the circulation by a carrier-mediated trans-
port process.
Thus we have shown that PGE1, PGF2., but not
PGA1 nor PGB1, were accumulated in the lung by
the carrier-mediated process. The presence of a
second unlabeled PG in the perfusate inhibited
both the metabolism and uptake of a labeled PG
(Fig. 7). The uptake of PGE1 in the presence of 5
nmole/ml of PGE2 was reduced. The Vmax for
PGEI was unaltered by PGE2 while the Km of
PGE1 increased. Thus, PGE2 was a competitive
inhibitor of PGE,. This again is consistent with
the hypothesis that PGs are accumulated in lung
by a carrier-mediated transport process.
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FIGURE 7. Dependence of the uptake velocity of PGE. into the
IPL on the supply rate. Data plotted in the form of a Woolf
plot of (ordinate) vs. the ratio of the supply rate to the up-
take velocity; the supply rate (nmole/sec) (abscissa): the
dashed line is uptake velocity in the absence of PGE2; the
solid line is uptake velocity in the presence of 5 nmole
PGE2/ml.
Thus, the inactivation system for PG in rat
lung consists of a transport system and subse-
quent enzymatic inactivation. The relative effec-
tiveness ofthese systems is shown in Figure 8. At
a low supply rate, approximately 80% of PGE1
was removed (into lung) and inactivated. As the
supply rate increased, the percentage removal of
PGEO slowly decreased to 20%. However, the
percentage degradation of PGE1 decreased very
rapidly with increasing supply rate, and this re-
moved, but unmetabolized PGE1, returned to the
circulation. Thus, at low concentrations the
transport system is rate limiting while at higher
concentrations the enzymatic inactivation be-
comes rate-limiting.
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FIGURE 8. Effect of supply rate on the percentage removal and
metabolism of PGE, by IPL. The ordinate shows percentage
removal of metabolism; the abscissa gives supply rate
(nmoles/sec).
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80In conclusion, we have developed and used an
isolated perfused lung system that allows ex-
amination of the uptake, accumulation, metabo-
lism and release ofchemicals by the lung. Studies
on some aspects ofthis problem would be difficult
or impossible without the IPL preparation. We
think that the system is highly suitable for the
following: studies on the transport and metabolism
of chemicals by lung; examination of accumula-
tion of chemicals by lung; studies on metabolism
of inhaled as well as circulating substances; in-
vestigation of the release of substances by the
lung into the circulation or studies of the en-
docrine function of the lung. We believe that the
IPL is a valuable tool in examination of these
nonrespiratory lungfunctions.
We would like to acknowledge the contributions of Drs.
Orton, Pickett, Law, and Wilson tothis research.
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